Pharmaceutical Industry Information Portal

HomeNews

News

Perm subsidiary of NPO Microgen to expand the production of vaccines and blood products

Rostec and the Perm Krai signed a memorandum on co-operation in implementation of two large investment projects. Within the partnership, a new vaccine production...

BIOCAD has received approval from the Chinese authorities to conduct clinical trials of prololimab for the treatment of cervical cancer and NSCLC

SPH BIOCAD, a joint venture with Shanghai Pharmaceuticals Holding, which is registered in Hong Kong and has a representative office in Shanghai, has received...

Microgen obtained registration for the new vaccine

NPO Microgen (managed by Nacimbio of Rostec State Corporation) announced the registration of bivalent polysaccharide vaccine for the prevention of meningococcal infection by the...

Solopharm new plant construction

On September 4 of 2020, the groundbreaking ceremony of the second Solopharm pharmaceutical plant was held. The second plant will produce medicines in tablets...

Transition of Veterinary Manufacturers to the EAEU GMP Rules

In October 2020, the Federal Service for Veterinary and Phytosanitary Surveillance (Rosselkhoznadzor) announced that from January 1, 2021, the Rules of Good Manufacturing Practice...
spot_img

Expert Articles

spot_img